Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 21, 2010
Patent Application Number
11559332
Date Filed
November 13, 2006
Patent Primary Examiner
Patent abstract
Tumor necrosis factors and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human tumor necrosis factor receptor designated as “Ztnfr12.”
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
